Results 81 to 90 of about 21,217 (292)

Healthcare Resource Utilization and Use of Biologics in Chronic Spontaneous Urticaria

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Biologic therapies have emerged as effective treatments for chronic spontaneous urticaria (CSU), a debilitating skin disease. However, real‐world data on their use are limited. This retrospective descriptive study analyzes the time from diagnosis to biologic therapy initiation and the CSU‐specific healthcare resource utilization (HCRU) among ...
Lillian D. Sun   +7 more
wiley   +1 more source

The Hair Dilemma: Conform to Mainstream Expectations or Emphasize Racial Identity [PDF]

open access: yes, 2007
Throughout American history, skin color, eye color, and hair texture have had the power to shape the quality of Black people\u27s lives, and that trend continues today for Black women in the ...
Dumas, Tracy L.   +1 more
core   +1 more source

The Role of Imaging Techniques in Pigmented Bowen Disease and Lentigo Maligna of the Head and Neck: A Comparative Dermoscopic and Reflectance Confocal Microscopy Study

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Pigmented Bowen disease (pBD) may closely mimic lentigo maligna (LM) both clinically and dermoscopically. Accurate differentiation between these entities is clinically crucial, as misclassification may lead to overtreatment or undertreatment. Noninvasive imaging techniques, including dermoscopy and reflectance confocal microscopy (RCM), have ...
Federico Venturi   +6 more
wiley   +1 more source

A Curious Case of Patterned Scarring Alopecia

open access: yes
JEADV Clinical Practice, EarlyView.
Jeta Buch   +3 more
wiley   +1 more source

Real‐World Outcomes of Baricitinib and Ritlecitinib in Refractory Alopecia Areata: Response Predictors and Relapse After Discontinuation or Dose Reduction

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Baricitinib and ritlecitinib are newly approved systemic Janus kinase (JAK) inhibitors for severe, refractory alopecia areata (AA). Although clinical trials have demonstrated their efficacy, real‐world evidence remains limited, particularly regarding predictors of response and outcomes following treatment interruption or dose tapering.
Rina Hayashi   +2 more
wiley   +1 more source

A Case Series of Rare Long-Term Bruising Following Injection of Liquid-Form Polycaprolactone: Mechanisms and Therapeutic Insights

open access: yesClinical, Cosmetic and Investigational Dermatology
Hyeonseob Byeon,1,* Halim Baek,2,* Vasanop Vachiramon,3,* Youngjin Park,4,* Kyungtae Bae,5,* Kateryna Chymber,6 Jaeyun Jung,7 Xue Li,8 Seunghyeon Lee,9 Sheau Jye Teh,10 Olha Shestakova,9 Chanjong Lee,9 Rassapoom ...
Byeon H   +12 more
doaj  

Development of “Core Syllabus” for Facial Anatomy Teaching to Aesthetic Physicians: A Delphi Consensus [PDF]

open access: yes, 2018
Background: A detailed understanding of facial anatomy, specifically the vascular framework, is crucial for delivering safe nonsurgical aesthetic procedures.
Bland   +22 more
core   +2 more sources

Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Vitiligo is a chronic autoimmune depigmenting disease characterized by loss of pigment in the skin, hair, or both. As treatment options evolve, particularly with the emergence of oral Janus kinase inhibitors and dual Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor, it is essential to assess ...
Kennedy Cook   +11 more
wiley   +1 more source

Tapinarof as a Therapeutic Aryl Hydrocarbon Receptor‐Modulating Agent in the Treatment of Atopic Dermatitis

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Atopic dermatitis (AD) is a chronic inflammatory dermatitis underpinned by Type 2 inflammation driven by cytokines such as IL‐4 and IL‐13. It is characterized by skin barrier dysfunction, Th2 immune deviation, and pruritus. While biologics and oral Janus kinase (JAK) inhibitors demonstrate high therapeutic efficacy by targeting cytokines that ...
Gaku Tsuji   +7 more
wiley   +1 more source

Lasers in tattoo and pigmentation control: role of the PicoSure(®) laser system. [PDF]

open access: yes, 2016
BACKGROUND AND OBJECTIVES: The use of picosecond lasers to remove tattoos has greatly improved due to the long-standing outcomes of nanosecond lasers, both clinically and histologically. The first aesthetic picosecond laser available for this use was the
Bankowski, Richard   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy